Cleared Traditional

HPACS (K250039) - FDA 510(k) Clearance

Class II Radiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2025
Decision
268d
Days
Class 2
Risk

K250039 is an FDA 510(k) clearance for the HPACS. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Healthhub (Seoul, KR). The FDA issued a Cleared decision on October 3, 2025 after a review of 268 days - an extended review cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate-to-high equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Healthhub devices

Submission Details

510(k) Number K250039 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 08, 2025
Decision Date October 03, 2025
Days to Decision 268 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
161d slower than avg
Panel avg: 107d · This submission: 268d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 799
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K250039.
Viewer (5.4)
K252476 · Brainlab AG · Oct 2025
AGFA HealthCare Enterprise Imaging
K252199 · Agfa Healthcare N.V. · Oct 2025
ProKnow DS
K251363 · Elekta Solutions AB · Oct 2025
Philips IntelliSpace Cardiovascular
K251215 · Philips Medical Systems Nederland B.V. · Oct 2025
uWS-Angio Pro
K250045 · Shanghai United Imaging Healthcare Co., Ltd. · Sep 2025
uWS-Angio
K250040 · Shanghai United Imaging Healthcare Co., Ltd. · Sep 2025